Difficulty: Medium
Average Score: 69%
Practice
Which of the following M-cholinoblocking agents is used especially as an anti-asthmatic?
Correct answer
B
Rationale
In the context of pharmacology across the lifespan, understanding the use of M-cholinoblocking agents is crucial. In this question, the correct answer is B) Ipratropium, which is used especially as an anti-asthmatic agent.
Ipratropium is a bronchodilator that works by blocking the action of acetylcholine at M-cholinergic receptors in the bronchial smooth muscle, thereby leading to bronchodilation. It is commonly used in the management of chronic obstructive pulmonary disease (COPD) and asthma due to its ability to relax the muscles around the airways, making it easier to breathe.
Now, let's analyze why the other options are incorrect:
A) Atropine is a non-selective competitive antagonist of acetylcholine receptors and is not typically used as an anti-asthmatic agent.
C) Platyphylline is not commonly used in the treatment of asthma and does not have the same bronchodilator effects as ipratropium.
D) Metacin is not a commonly used medication for asthma and does not have the same mechanism of action as ipratropium.
Understanding the specific uses and mechanisms of action of different medications is essential in pharmacology to ensure safe and effective treatment for patients across the lifespan. In the case of asthma management, selecting the appropriate bronchodilator such as ipratropium is crucial for improving respiratory function and quality of life for patients.
Ipratropium is a bronchodilator that works by blocking the action of acetylcholine at M-cholinergic receptors in the bronchial smooth muscle, thereby leading to bronchodilation. It is commonly used in the management of chronic obstructive pulmonary disease (COPD) and asthma due to its ability to relax the muscles around the airways, making it easier to breathe.
Now, let's analyze why the other options are incorrect:
A) Atropine is a non-selective competitive antagonist of acetylcholine receptors and is not typically used as an anti-asthmatic agent.
C) Platyphylline is not commonly used in the treatment of asthma and does not have the same bronchodilator effects as ipratropium.
D) Metacin is not a commonly used medication for asthma and does not have the same mechanism of action as ipratropium.
Understanding the specific uses and mechanisms of action of different medications is essential in pharmacology to ensure safe and effective treatment for patients across the lifespan. In the case of asthma management, selecting the appropriate bronchodilator such as ipratropium is crucial for improving respiratory function and quality of life for patients.